PUBLISHER: The Business Research Company | PRODUCT CODE: 1877499
PUBLISHER: The Business Research Company | PRODUCT CODE: 1877499
Artificial intelligence-driven remote cardiac rehabilitation refers to a technology-based program that utilizes AI to remotely monitor and assess a patient's heart health and recovery progress. It provides personalized exercise programs, medication reminders, and real-time guidance through wearable devices and telehealth platforms.
The primary components of artificial intelligence-driven remote cardiac rehabilitation include software, hardware, and services. Software consists of a set of instructions, programs, or data that direct a computer or digital device to perform specific functions. It is delivered through web-based, app-based, and telehealth platforms, and can be deployed either on cloud-based systems or on-premises. The technology is applied in managing chronic heart failure, post-myocardial infarction, post-cardiac surgery, hypertension, and other related conditions, serving end users such as hospitals and clinics, homecare settings, rehabilitation centers, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The artificial intelligence (AI)-driven remote cardiac rehab market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-driven remote cardiac rehab market statistics, including artificial intelligence (AI)-driven remote cardiac rehab industry global market size, regional shares, competitors with an artificial intelligence (AI)-driven remote cardiac rehab market share, detailed artificial intelligence (AI)-driven remote cardiac rehab market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-driven remote cardiac rehab industry. This artificial intelligence (AI)-driven remote cardiac rehab market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence (AI)-driven remote cardiac rehab market size has grown exponentially in recent years. It will grow from $1.16 billion in 2024 to $1.40 billion in 2025 at a compound annual growth rate (CAGR) of 21.5%. The growth during the historic period can be attributed to the increasing elderly population, greater awareness of cardiac rehabilitation, expansion of telehealth adoption, rising use of wearable health devices, and higher healthcare expenditure.
The artificial intelligence (AI)-driven remote cardiac rehab market size is expected to see exponential growth in the next few years. It will grow to $3.03 billion in 2029 at a compound annual growth rate (CAGR) of 21.2%. The growth during the forecast period can be attributed to the increasing demand for remote patient monitoring, rising adoption of artificial intelligence-enabled healthcare platforms, growing focus on personalized rehabilitation, expansion of home-based healthcare models, and improvement in reimbursement policies. Key trends in the forecast period include advancements in artificial intelligence algorithms, innovations in wearable and remote monitoring devices, progress in telehealth and app-based platforms, research and development in predictive analytics, and advancements in personalized digital rehabilitation solutions.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the artificial intelligence-driven remote cardiac rehabilitation market during the forecast period. Cardiovascular diseases are conditions that affect the heart and blood vessels, including heart attack, stroke, and hypertension. The rise in cardiovascular diseases is primarily caused by unhealthy lifestyle habits that contribute to obesity, high blood pressure, and elevated cholesterol levels, placing strain on the heart and arteries. Artificial intelligence-driven remote cardiac rehabilitation assists patients with cardiovascular diseases by monitoring heart health, customizing exercise and medication plans, and providing real-time feedback remotely, which enhances recovery, promotes adherence, and reduces hospital readmissions. For example, in August 2025, according to the National Institutes of Health, a government agency in the United States, between 2025 and 2050, the prevalence of cardiovascular diseases is projected to increase by 90 percent, mortality by 73 percent, and disability-adjusted life years by 55 percent, with deaths expected to rise from 20.5 million to 35.6 million. Therefore, the increasing prevalence of cardiovascular diseases is contributing to the growth of the artificial intelligence-driven remote cardiac rehabilitation market.
Major companies in the artificial intelligence-driven remote cardiac rehabilitation market are focusing on creating innovative solutions such as advanced connected health platforms that enable continuous remote monitoring, personalized rehabilitation programs, and greater patient engagement to improve cardiovascular outcomes. An advanced connected health platform is a digital system that combines wearable devices, sensors, mobile applications, and cloud-based analytics to monitor patients' health remotely, deliver customized care, and facilitate real-time communication between patients and healthcare professionals. For instance, in July 2025, OMRON Healthcare, a healthcare company based in Japan, partnered with Tricog Health Services Pvt. Limited, a medtech company based in India, to introduce KeeboHealth. This initiative aims to address the country's cardiac health challenges and support OMRON's Going for Zero vision, which focuses on eliminating cardiovascular events such as heart attacks and strokes. The platform enables real-time monitoring through OMRON's home electrocardiogram and blood pressure devices integrated with Tricog's artificial intelligence cardiac analysis, allowing early detection of heart problems and timely medical response. This solution helps lower hospitalization rates, enhances therapy compliance, and supports personalized cardiac health management.
In December 2024, Lupin Digital Health Ltd., a pharmaceutical company based in India, partnered with Medicover Hospitals to provide advanced post-operative cardiac rehabilitation. This collaboration aims to transform cardiac care in India by offering personalized, technology-supported at-home post-operative rehabilitation and continuous monitoring through Lupin Digital Health's Lyfe platform, which enhances patient recovery and treatment adherence. Medicover Hospitals is a healthcare provider in India specializing in artificial intelligence-driven remote cardiac rehabilitation.
Major players in the artificial intelligence (AI)-driven remote cardiac rehab market are Medtronic PLC, Philips Healthcare, Biofourmis Inc., Neurosoft Ltd., Cadence Health Solutions, Wellframe Inc., Amwell, Datos Health Ltd., VivaLNK Inc., Carda Health Inc., Heartbeat Health Inc., Cardihab Pty Ltd., Chanl Health Inc., HealthSnap Inc., Kento Health Inc., Lyfe by Lupin Digital Health, Movn Health Inc., RecoveryPlus Health, Wellinks Inc., and CardioCare Fit.
North America was the largest region in the artificial intelligence (AI)-driven remote cardiac rehab market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-driven remote cardiac rehab report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the artificial intelligence (AI)-driven remote cardiac rehab market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artificial intelligence (AI)-driven remote cardiac rehab market consists of revenues earned by entities by providing services such as remote patient monitoring, teleconsultation, personalized exercise coaching, dietary and lifestyle counseling, mental health support, medication management, and data analytics and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-driven remote cardiac rehab market also includes sales of wearable heart rate monitors, blood pressure monitors, electrocardiogram devices, pulse oximeters, and fitness trackers. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence (AI)-Driven Remote Cardiac Rehab Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence (ai)-driven remote cardiac rehab market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial intelligence (ai)-driven remote cardiac rehab ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-driven remote cardiac rehab market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.